Access to medicines a talking point at World Health Assembly 2016
IAPO will be attending the 69th session of the World Health Organization's (WHO) World Health Assembly (WHA) meeting in Geneva from 23-28 May 2016.
This is due to our official relations with WHO, coordinated through their Patients for Patient Safety (PFPS) programme and person-centred and integrated health services strengthening work.
Discussions in 2016
The World Health Assembly is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board in January. The World Health Assembly agrees and oversees the policies, programme and budget of WHO.
The meeting will be discussing reports on access to essential medicines and on biotherapeutics (which include biologics and biosimilars), both crucial issues for patients and patients groups worldwide.
A member invitation
We would like to invite members to apply to attend the meeting within IAPO’s delegation. The draft agenda and papers are available to view as they become available, and the meeting can be followed by webcast (also via links on the same web page). Members have attended in the past, usually when there is an agenda item related to their disease area, or if they have other advocacy opportunities in Geneva at the same time.
Please note: members must pay their own costs for attending including flights, accommodation, making any arrangements for visas and other meetings or expenses. Members should submit the name, position, and a passport style photo to email@example.com along with an email expressing interest, by 15 April.